Back to Agenda
Session 0105: EVOLVEMENT IN DIABETES AND OBESITY PREVENTION AND TREATMENT - IMPACT ON DRUG DEVELOPMENT
Session Chair(s)
Jessica Liu, MD
VP, Head of Merges and Acquisition Management Department
Tigermed Consulting Co., Ltd, China
Diabetes and obesity special discussion will invite well-known Chinese diabetes expert to share the landscape of diabetes incidence in China and the research progress on preventing; Foreign experts on drug development will share their rich experience on designing diabetes drug development plan and the choice of assessment endpoints, eventually how to cooperate with the authorities on efficacy and safety requirements and evaluation.
Speaker(s)
Early Phase Clinical Research and Development For Diabetes and Obesity
Marcus Hompesch, MD
Profil Institute for Clinical Research, United States
President & CEO
New Model to Tackle the Operational Challenges in Diabetes Drug Clinical Development
Andreas Koester, MD, PhD
Janssen Research & Development, LLC, United States
Vice President and Global Head, Clinical Innovation
Quality Control for Multi-Center Clinical Trials
Jim Wang
Novo Nordisk A/S, China
Senior Director
Have an account?